Ultraviolet light-based pathogen inactivation and alloimmunization after platelet transfusion: results from a randomized trial.

The current study was not sufficiently powered to determine whether pathogen-reduction treatment provides protection from human leukocyte antigen alloimmunization in platelet transfusion recipients. The data presented will be useful in the design of future trials and endpoints powered to detect a protective effect.